Euclidean Capital as of Sept. 30, 2024
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 12 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 76.1 | $690M | 1.2M | 573.76 | |
| Ishares Tr Msci India Etf (INDA) | 15.7 | $142M | 2.4M | 58.53 | |
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 3.5 | $32M | 508k | 63.00 | |
| Foghorn Therapeutics (FHTX) | 1.6 | $15M | 1.6M | 9.31 | |
| Oric Pharmaceuticals (ORIC) | 1.1 | $10M | 989k | 10.25 | |
| Alector (ALEC) | 0.7 | $6.1M | 1.3M | 4.66 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $3.9M | 2.6M | 1.49 | |
| 23andme Holding Class A Com | 0.4 | $3.6M | 10M | 0.35 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $2.0M | 1.0M | 1.93 | |
| Rapt Therapeutics | 0.1 | $1.3M | 658k | 2.01 | |
| Surrozen Com New (SRZN) | 0.1 | $1.1M | 88k | 11.98 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.8k | 171k | 0.01 |
